7 Products Boston Scientific is Betting on in 2014: Alair Bronchial Thermoplasty System

Alair Bronchial Thermoplasty System The first FDA-approved nondrug outpatient procedure to treat severe and persistent asthma, Alair saw 25% growth last year and is now offered at more than 350 worldwide treatment sites. Mahoney said reorder rates are improving and large commercial insurers are greenlighting it for more case-by-case approvals.

Alair Bronchial Thermoplasty System

The first FDA-approved nondrug outpatient procedure to treat severe and persistent asthma, Alair saw 25% growth last year and is now offered at more than 350 worldwide treatment sites. Mahoney said reorder rates are improving and large commercial insurers are greenlighting it for more case-by-case approvals.

IntroductionPremier 

 

 

 

[image courtesy of BOSTON SCIENTIFIC]

Filed Under
500 characters remaining